Arbutus Biopharma Corp. (ABUS)
5.15
+0.03
(+0.59%)
USD |
NASDAQ |
Sep 04, 16:00
5.15
0.00 (0.00%)
Pre-Market: 20:00
Arbutus Biopharma Cash and Short Term Investments (Annual) : 91.47M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 91.47M |
| December 31, 2024 | 122.62M |
| December 31, 2023 | 126.00M |
| December 31, 2022 | 146.91M |
| December 31, 2021 | 155.32M |
| December 31, 2020 | 123.27M |
| December 31, 2019 | 90.83M |
| December 31, 2018 | 124.62M |
| December 31, 2017 | 126.35M |
| December 31, 2016 | 130.56M |
| December 31, 2015 | 181.30M |
| December 31, 2014 | 112.16M |
| December 31, 2013 | 68.72M |
| December 31, 2012 | 46.99M |
| December 31, 2011 | 9.020M |
| Date | Value |
|---|---|
| December 31, 2010 | 12.42M |
| December 31, 2009 | 23.27M |
| December 31, 2008 | 25.88M |
| December 31, 2007 | 21.20M |
| December 31, 2006 | 4.873M |
| December 31, 2005 | 10.42M |
| December 31, 2004 | 25.08M |
| December 31, 2003 | 39.34M |
| December 31, 2002 | 38.04M |
| December 31, 2001 | 47.43M |
| December 31, 2000 | 23.93M |
| December 31, 1999 | 19.57M |
| December 31, 1998 | 6.469M |
| December 31, 1997 | 18.54M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Moderna, Inc. | 5.80B |
| Insmed, Inc. | 1.430B |
| Pfizer Inc. | 13.60B |
| Gossamer Bio, Inc. | 136.93M |
| Legend Biotech Corp. | 948.60M |